On May 22nd, the Department of Justice (“DOJ”) and Federal Trade Commission (“FTC”) filed a joint Statement of Interest in a ...

FDA’s Office of Prescription Drug Promotion (OPDP) is active throughout each year issuing letters challenging promotional ...